172 related articles for article (PubMed ID: 12568782)
1. Toxicokinetics in preclinical evaluation.
Baldrick P
Drug Discov Today; 2003 Feb; 8(3):127-33. PubMed ID: 12568782
[TBL] [Abstract][Full Text] [Related]
2. Concomitant toxicokinetics: techniques for and interpretation of exposure data obtained during the conduct of toxicology studies.
Dahlem AM; Allerheiligen SR; Vodicnik MJ
Toxicol Pathol; 1995; 23(2):170-8. PubMed ID: 7569672
[TBL] [Abstract][Full Text] [Related]
3. Study design and statistical analysis of toxicokinetics: a report of JPMA investigation of case studies.
Igarashi T; Yabe T; Noda K
J Toxicol Sci; 1996 Dec; 21(5):497-504. PubMed ID: 9035061
[TBL] [Abstract][Full Text] [Related]
4. [Significance of ICH--toxicokinetics guidance and its practice--a useful approach for safety drug development].
Tsuda M; Ohno Y
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):1-14. PubMed ID: 9641814
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic and metabolic studies in the development of drugs].
Vereczkey L
Acta Pharm Hung; 1995 Jul; 65(4):105-11. PubMed ID: 7572191
[TBL] [Abstract][Full Text] [Related]
6. Providing toxicokinetic support for reproductive toxicology studies in pharmaceutical development.
Schwartz S
Arch Toxicol; 2001 Sep; 75(7):381-7. PubMed ID: 11693177
[TBL] [Abstract][Full Text] [Related]
7. Safety evaluation to support First-In-Man investigations I: kinetic and safety pharmacology studies.
Baldrick P
Regul Toxicol Pharmacol; 2008 Jul; 51(2):230-6. PubMed ID: 18501489
[TBL] [Abstract][Full Text] [Related]
8. Sparse sampling for assessment of drug exposure in toxicological studies.
Burtin P; Mentre F; van Bree J; Steimer JL
Eur J Drug Metab Pharmacokinet; 1996; 21(2):105-11. PubMed ID: 8839683
[TBL] [Abstract][Full Text] [Related]
9. Differences between pharmacokinetics and toxicokinetics.
Welling PG
Toxicol Pathol; 1995; 23(2):143-7. PubMed ID: 7569668
[TBL] [Abstract][Full Text] [Related]
10. Application of toxicokinetics to improve chemical risk assessment: implications for the use of animals.
Creton S; Billington R; Davies W; Dent MP; Hawksworth GM; Parry S; Travis KZ
Regul Toxicol Pharmacol; 2009 Dec; 55(3):291-9. PubMed ID: 19665509
[TBL] [Abstract][Full Text] [Related]
11. Use of toxicokinetics to support chemical evaluation: Informing high dose selection and study interpretation.
Creton S; Saghir SA; Bartels MJ; Billington R; Bus JS; Davies W; Dent MP; Hawksworth GM; Parry S; Travis KZ
Regul Toxicol Pharmacol; 2012 Mar; 62(2):241-7. PubMed ID: 22198561
[TBL] [Abstract][Full Text] [Related]
12. Safety assessment of biotechnology-derived pharmaceuticals: ICH and beyond.
Serabian MA; Pilaro AM
Toxicol Pathol; 1999; 27(1):27-31. PubMed ID: 10367669
[TBL] [Abstract][Full Text] [Related]
13. Dose selection for toxicity studies: a protocol for determining the maximum repeatable dose.
Spurling NW; Carey PF
Hum Exp Toxicol; 1992 Nov; 11(6):449-57. PubMed ID: 1361132
[TBL] [Abstract][Full Text] [Related]
14. The impact of molecular biology on drug discovery.
Belfield GP; Delaney SJ
Biochem Soc Trans; 2006 Apr; 34(Pt 2):313-6. PubMed ID: 16545102
[TBL] [Abstract][Full Text] [Related]
15. Toxicokinetics in drug development: an overview of toxicokinetic application in the development of PNU-101017, an anxiolytic drug candidate.
Zhong WZ; Williams MG; Branstetter DG
Curr Drug Metab; 2000 Nov; 1(3):243-54. PubMed ID: 11465047
[TBL] [Abstract][Full Text] [Related]
16. Bridging from preclinical to clinical studies for tyrosine kinase inhibitors based on pharmacokinetics/pharmacodynamics and toxicokinetics/toxicodynamics.
Hoshino-Yoshino A; Kato M; Nakano K; Ishigai M; Kudo T; Ito K
Drug Metab Pharmacokinet; 2011; 26(6):612-20. PubMed ID: 21897052
[TBL] [Abstract][Full Text] [Related]
17. Drugs in control samples in nonclinical safety studies: a reconsideration.
Zimmer D
Bioanalysis; 2016 May; 8(10):1003-7. PubMed ID: 27080047
[No Abstract] [Full Text] [Related]
18. Methodological approaches to the population analysis of toxicity data.
Aarons L; Graham G
Toxicol Lett; 2001 Mar; 120(1-3):405-10. PubMed ID: 11323200
[TBL] [Abstract][Full Text] [Related]
19. Toxicokinetics in the evaluation of toxicity data.
Watanabe PG; Schumann AM; Reitz RH
Regul Toxicol Pharmacol; 1988 Dec; 8(4):408-13. PubMed ID: 3222482
[TBL] [Abstract][Full Text] [Related]
20. Ancillary approaches to toxicokinetic evaluations.
Takacs AR
Toxicol Pathol; 1995; 23(2):179-86. PubMed ID: 7569673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
